BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28299674)

  • 1. The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.
    Voon DC; Thiery JP
    Adv Exp Med Biol; 2017; 962():471-489. PubMed ID: 28299674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression.
    Pilli VS; Gupta K; Kotha BP; Aradhyam GK
    FEBS Lett; 2015 May; 589(11):1249-56. PubMed ID: 25889638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.
    Bogachek MV; De Andrade JP; Weigel RJ
    Cancer Res; 2015 Jan; 75(1):11-5. PubMed ID: 25524900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of RUNX in Solid Tumors.
    Chuang LS; Ito K; Ito Y
    Adv Exp Med Biol; 2017; 962():299-320. PubMed ID: 28299665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M
    Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
    Huang R; Zong X
    Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
    Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
    Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition.
    Li H; Li M; Xu D; Zhao C; Liu G; Wang F
    Biochem Biophys Res Commun; 2014 Mar; 446(1):347-51. PubMed ID: 24607896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
    Huang W; Zhu S; Liu Q; Li C; Li L
    Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
    Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
    Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.
    Kahlert UD; Joseph JV; Kruyt FAE
    Mol Oncol; 2017 Jul; 11(7):860-877. PubMed ID: 28556516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
    Cervantes-Arias A; Pang LY; Argyle DJ
    Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
    Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
    Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epithelial to mesenchymal transition by bone morphogenetic proteins.
    McCormack N; O'Dea S
    Cell Signal; 2013 Dec; 25(12):2856-62. PubMed ID: 24044921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis.
    Jayachandran A; Königshoff M; Yu H; Rupniewska E; Hecker M; Klepetko W; Seeger W; Eickelberg O
    Thorax; 2009 Dec; 64(12):1053-61. PubMed ID: 19850962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
    Kobayashi W; Ozawa M
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.